Publications

2017

Shah K, Tran AN, Magro CM, Zang JB. Treatment of Kimura disease with mycophenolate mofetil monotherapy. JAAD Case Rep. 2017;3(5):416-419.
Aukes K, Forsman C, Brady NJ, Astleford K, Blixt N, Sachdev D, et al. Breast cancer cell-derived fibroblast growth factors enhance osteoclast activity and contribute to the formation of metastatic lesions. PLoS One. 2017;12(10):e0185736.
Hainline C, Rucker JC, Zagzag D, Golfinos JG, Lui YW, Liechty B, et al. Tumoral Presentation of Homonymous Hemianopia and Prosopagnosia in Cerebral Amyloid Angiopathy-Related Inflammation. J Neuroophthalmol. 2017;37(1):48-52.
Halteh P, Magro C, Lipner SR. Angiolymphoid hyperplasia with eosinophilia of the nail unit. Dermatol Online J. 2017;23(6).
Alter RA, White TG, Fanous AA, Chakraborty S, Filippi CG, Pisapia DJ, et al. Long-term benefit of intra-arterial bevacizumab for recurrent glioblastoma. J Exp Ther Oncol. 2017;12(1):67-71.
Chadburn A, Said J, Gratzinger D, Chan JK, de Jong D, Jaffe ES, et al. HHV8/KSHV-Positive Lymphoproliferative Disorders and the Spectrum of Plasmablastic and Plasma Cell Neoplasms: 2015 SH/EAHP Workshop Report-Part 3. Am J Clin Pathol. 2017;147(2):171-187.
Chen M, Nowak DG, Narula N, Robinson B, Watrud K, Ambrico A, et al. The nuclear transport receptor Importin-11 is a tumor suppressor that maintains PTEN protein. J Cell Biol. 2017;216(3):641-656.
Fajgenbaum DC, Uldrick TS, Bagg A, Frank D, Wu D, Srkalovic G, et al. International, evidence-based consensus diagnostic criteria for HHV-8-negative/idiopathic multicentric Castleman disease. Blood. 2017;129(12):1646-1657.
Marchionni L, Hayashi M, Guida E, Ooki A, Munari E, Jabboure FJ, et al. MicroRNA expression profiling of Xp11 renal cell carcinoma. Hum Pathol. 2017;67:18-29.

Pathology & Laboratory Medicine 1300 York Avenue New York, NY 10065 Phone: (212) 746-6464
Surgical Pathology: (212) 746-2700